TH155656A - Salt and solid form of (S) -3- (4 - ((4-morpholinomethyl) benzyl) oxy) -1-oxo isoindolin-2-i L) piperidine-2,6-dion And the elements which include And the method of using the same substance - Google Patents
Salt and solid form of (S) -3- (4 - ((4-morpholinomethyl) benzyl) oxy) -1-oxo isoindolin-2-i L) piperidine-2,6-dion And the elements which include And the method of using the same substanceInfo
- Publication number
- TH155656A TH155656A TH1501000645A TH1501000645A TH155656A TH 155656 A TH155656 A TH 155656A TH 1501000645 A TH1501000645 A TH 1501000645A TH 1501000645 A TH1501000645 A TH 1501000645A TH 155656 A TH155656 A TH 155656A
- Authority
- TH
- Thailand
- Prior art keywords
- solid form
- salt
- dion
- morpholinomethyl
- piperidine
- Prior art date
Links
- 239000007787 solid Chemical group 0.000 title claims abstract 11
- 150000003839 salts Chemical group 0.000 title claims abstract 9
- 239000000126 substance Substances 0.000 title claims abstract 8
- -1 (4-morpholinomethyl) benzyl Chemical group 0.000 title claims abstract 7
- 238000000034 method Methods 0.000 title claims abstract 5
- KNCYXPMJDCCGSJ-UHFFFAOYSA-N piperidine-2,6-dione Chemical compound O=C1CCCC(=O)N1 KNCYXPMJDCCGSJ-UHFFFAOYSA-N 0.000 title claims abstract 5
- 239000000470 constituent Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 238000002441 X-ray diffraction Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
Abstract
แก้ไขบทสรุปการประดิษฐ์ 30/4/2558 เปิดเผยเกลือและรูปของแข็งของ 3-(4-((4-(มอร์ฟอลิโนเมธิล)เบนซิล)ออกซิ)-1- ออกโซไอโซอินโดลิน-2-อิล)ไพเพอริดีน-2,6-ไดโอน,หรือ สเตอริโอเมอร์ของสารเหล่านี้ นอกจากนี้ ยังเปิดเผยถึงองค์ประกอบซึ่งประกอบรวมด้วยสารดังกล่าวและวิธีของการใช้เกลือและรูป ของแข็ง --------------------------------------------------------------------- คำขอใหม่ปรับปรุง เปิดเผยเกลือและรูปของแข็งของ 3-(4-((4-(มอร์ฟอลิโนเมธิล)เบนซิล)ออกซิ)-1-ออกโซไอโซ อินโดลิน-2-อิล)ไพเพอริดีน-2,6-ไดโอน, หรือสเตอริโอเมอร์ของสารเหล่านี้, นอกจากนี้ยังเปิดเผยถึง องค์ประกอบซึ่งประกอบรวมด้วยสารดังกล่าว และวิธีของการใช้เกลือ และรูปของแข็ง สิทธิบัตรยา Revised invention summary 4/30/2015 Revealed salt and solid form of 3- (4 - ((4- (morpholinomethyl) benzyl) oxy) -1-oxoisoindolin-2-il) piperidine - 2,6-Dion, or Steromers of these substances also reveal their constituents and methods of using salt and solid form. -------------------- ------------------------------------------------- Request New update Reveal salt and solid form of 3- (4 - ((4- (morpholinomethyl) benzyl) oxy) -1-oxoiso Indolin-2-il) piperidine-2,6-dion, or steromer of these substances, also revealed to The composition of the said substance And methods of using salt And a solid form of patent medicine
Claims (3)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH155656A true TH155656A (en) | 2016-09-06 |
| TH1501000645A TH1501000645A (en) | 2016-09-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014221779A5 (en) | ||
| EA201892119A1 (en) | DRUGS, OBTAINED BY COMBINING AGONIST FXR AND ARB | |
| MX2016010266A (en) | Crystalline solid forms of n-{4-[(6,7-dimethoxyquinolin-4-yl)oxy] phenyl}-n'-(4-fluorophenyl) cyclopropane-1, 1-dicarboxamide, processes for making, and methods of use. | |
| JP2016533366A5 (en) | ||
| EA201201263A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING DAGIGATRAN ETEXYLATE | |
| RU2018119102A (en) | THERAPEUTIC FOR TREATMENT OF BREAST CANCER | |
| MY174343A (en) | Novel heterocyclic compound | |
| TH155656A (en) | Salt and solid form of (S) -3- (4 - ((4-morpholinomethyl) benzyl) oxy) -1-oxo isoindolin-2-i L) piperidine-2,6-dion And the elements which include And the method of using the same substance | |
| EP4027974C0 (en) | Pharmaceutical composition containing p-boronophenylalanine | |
| TH169335A (en) | ||
| TH1601002685A (en) | Solid form of {[5- (3- chlorophenyl) -3-hydroxypyridine-2-carbonyl] amino} acetic acid, composition and use of that substance. | |
| TH168760A (en) | Benzophuranyl and benzoxazolyl compounds that are replaced And the use of that | |
| TH152806A (en) | Solid form. 3- (5-amino-2-methyl-4-oxo-4H-quinazolin-3-il) -piperidine-2,6-dion, and composition Pharmaceuticals of those substances and their use. | |
| TH167729A (en) | 2-amino-6-methyl -4,4a, 5,6-tetrahydropyrano [3,4-d] [1,3] thiazin-8a (8H) - il- 1,3-thiazole-4-il amide | |
| TH1701004077A (en) | Active substance for improving early insulin secretion capacity. | |
| TH1701002157A (en) | Crystal form of 5- Chloro-N4- [2- (dimethylphosphoril) phenyl] -N2- {2-moxy-4- [4- (4-methyl Piperacin-1-il) Piperidin-1-il] pyrimidin-2,4-diamine | |
| TH174458A (en) | Pharmaceutical solids containing biotherin derivatives And the use of such elements | |
| TH165767A (en) | Substituteed compound Dihydroisokinolinone | |
| TH154051A (en) | Serine / threonine kinase inhibitor | |
| TH1701003406A (en) | Pharmaceutical formulation of tropomieosin-related kinase inhibitors (TRK). | |
| TH1601006691A (en) | ||
| TH1701000118A (en) | Compounds that resist cell proliferation and methods for their use | |
| TH168688A (en) | Crystalline salt of (S) -6 - ((1- acetylpiperidin-4-il) amino) -N- (3- (3,4-dihydroisokinolin-) 2 (1H) - il) - hydroxypropyl) pyrimidine-4-carboxamide | |
| TH1801001807A (en) | An isoindolinone inhibitor of MDM2-P53 interaction with anticancer activity. | |
| TH168956A (en) | MEK inhibitors and compounds |